Literature DB >> 2088459

Recurrent haemolytic uraemic syndrome and acquired hypomorphic variant of the third component of complement.

A M Roodhooft1, R H McLean, E Elst, K J Van Acker.   

Abstract

In a girl with recurrent haemolytic uraemic syndrome (HUS), persistently low serum levels of C3 were found. Analysis of complement phenotype revealed a hypomorphic variant of C3 Fast in the patient (C3fS) and a normal heterozygous pattern in both parents and the brother (C3FS). Other complement aberrations in the patient were: the presence of a null gene for C4A and C4B and low serum levels of factor H. The father also had partial factor H deficiency. It is hypothesized that the hypomorphic C3 variant may predispose to recurrent HUS. In the acquired forms the role of uraemia in alteration of C3F should be considered.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2088459     DOI: 10.1007/BF00858631

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  11 in total

1.  ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.

Authors:  C B LAURELL
Journal:  Anal Biochem       Date:  1965-02       Impact factor: 3.365

2.  Hypomorphic variant of C3, arthritis, and chronic glomerulonephritis.

Authors:  R H McLean; A Weinstein; I Damjanov; N Rothfield
Journal:  J Pediatr       Date:  1978-12       Impact factor: 4.406

3.  Recurrent haemolytic-uraemic syndrome with hypocomplementaemia: a case report.

Authors:  R Bogdanović; A Cvorić; V Nikolić; M Sindjić
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

Review 4.  Genetically determined variation in the complement system: relationship to disease.

Authors:  R H McLean; J A Winkelstein
Journal:  J Pediatr       Date:  1984-08       Impact factor: 4.406

5.  Hypocomplementaemia due to a genetic deficiency of beta 1H globulin.

Authors:  R A Thompson; M H Winterborn
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

6.  Plasmapheresis in the haemolytic-uraemic syndrome in children.

Authors:  T J Beattie; A V Murphy; M L Willoughby; S J Machin; G Defreyn
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-23

7.  Hemolytic uremic syndrome with recurrent episodes: an important subset.

Authors:  B S Kaplan
Journal:  Clin Nephrol       Date:  1977-12       Impact factor: 0.975

8.  Familial hypocomplementemic hemolytic uremic syndrome with HLA-A3,B7 haplotype.

Authors:  L Carreras; R Romero; C Requesens; A J Oliver; M Carrera; M Clavo; J Alsina
Journal:  JAMA       Date:  1981-02-13       Impact factor: 56.272

9.  C4 uremic variant: an acquired C4 allotype.

Authors:  T R Welch; L Beischel
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

10.  Plasma exchanges in frequently recurrent hemolytic-uremic syndrome in a child.

Authors:  C M Feldhoff; W Luboldt; K Bussmann; K Schrör
Journal:  Int J Pediatr Nephrol       Date:  1983-12
View more
  9 in total

Review 1.  Genetic kidney diseases in the pediatric population of southern Israel.

Authors:  Gal Finer; Hanna Shalev; Daniel Landau
Journal:  Pediatr Nephrol       Date:  2006-05-30       Impact factor: 3.714

Review 2.  Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS): the new thinking.

Authors:  J Liu; M Hutzler; C Li; L Pechet
Journal:  J Thromb Thrombolysis       Date:  2001-05       Impact factor: 2.300

3.  Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition.

Authors:  A Richards; M R Buddles; R L Donne; B S Kaplan; E Kirk; M C Venning; C L Tielemans; J A Goodship; T H Goodship
Journal:  Am J Hum Genet       Date:  2001-01-17       Impact factor: 11.025

4.  Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries.

Authors:  H P H Neumann; M Salzmann; B Bohnert-Iwan; T Mannuelian; C Skerka; D Lenk; B U Bender; M Cybulla; P Riegler; A Königsrainer; U Neyer; A Bock; U Widmer; D A Male; G Franke; P F Zipfel
Journal:  J Med Genet       Date:  2003-09       Impact factor: 6.318

Review 5.  Pathogenesis of thrombotic microangiopathies.

Authors:  X Long Zheng; J Evan Sadler
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

Review 6.  Complement and glomerulonephritis--an update.

Authors:  R H McLean
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

Review 7.  The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children.

Authors:  Chantal Loirat; Patrick Niaudet
Journal:  Pediatr Nephrol       Date:  2003-09-17       Impact factor: 3.714

8.  Generation of complement protein C3 deficient pigs by CRISPR/Cas9-mediated gene targeting.

Authors:  Wei Zhang; Guan Wang; Ying Wang; Yong Jin; Lihua Zhao; Qiang Xiong; Lining Zhang; Lisha Mou; Rongfeng Li; Haiyuan Yang; Yifan Dai
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

Review 9.  Complement factor H and the hemolytic uremic syndrome.

Authors:  John P Atkinson; Timothy H J Goodship
Journal:  J Exp Med       Date:  2007-06-04       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.